You are here

HemCon Medical Technologies Inc

Company Information
Address
10575 SW Cascade Ave Suite 130
Portland, OR 97223-4363
United States


http://www.hemcon.com

Information

DUNS: 116661344

# of Employees: 29


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Chitosan Gastrointestinal Hemostatic Dressing

    Amount: $224,100.00

    ? DESCRIPTION (provided by applicant): Non-variceal upper gastrointestinal bleeding (NVUGIB) is a major cause of morbidity and mortality worldwide. Incidence of NVUGIB in the US is 53 events per 1 ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  2. Chitosan Endoluminal Hemostatic Dressing

    Amount: $892,569.00

    DESCRIPTION provided by applicant Perioperative hemorrhage remains the major complication of transurethral and open prostatic surgical procedures Significant blood loss from these procedures cause ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  3. Hemostatic Agent Development

    Amount: $70,000.00

    We will develop a novel hemostatic, antimicrobial, resorbable, nanofiber dressing utilizing proven hemorrhage control technology in combination with novel advanced technologies. The nanofiber dressing ...

    SBIRPhase I2010Department of Defense Navy
  4. Chitosan Endoluminal Hemostatic Dressing

    Amount: $226,185.00

    DESCRIPTION (provided by applicant): HemCon, Inc. PA-08-051 Chitosan Endoluminal Hemostatic Dressing Project Summary Abstract P.I. - Hua Xie Page 1 Co-PI - Simon McCarthy Abstract The goal of this pro ...

    STTRPhase I2009Department of Health and Human Services National Institutes of Health
  5. Chitosan hemostatic device for laparoscopic applications

    Amount: $231,982.00

    DESCRIPTION (provided by applicant): Intraoperative bleeding can be a serious problem in parenchymal organ surgery and is generally difficult to manage during laparoscopic procedures. Our long-term ...

    STTRPhase I2005Department of Health and Human Services National Institutes of Health
  6. Chitosan hemostatic device for laparoscopic applications

    Amount: $231,982.00

    DESCRIPTION (provided by applicant): Intraoperative bleeding can be a serious problem in parenchymal organ surgery and is generally difficult to manage during laparoscopic procedures. Our long-term ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government